Cargando…
P1389: RUXOLITINIB DEMONSTRATES A GREATER CORTICOSTEROID-SPARING EFFECT THAN BEST AVAILABLE THERAPY IN PATIENTS WITH CORTICOSTEROID-REFRACTORY/DEPENDENT CHRONIC GRAFT-VS-HOST DISEASE
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429566/ http://dx.doi.org/10.1097/01.HS9.0000848416.66197.62 |
| _version_ | 1784779493823479808 |
|---|---|
| author | Zeiser, R. Russo, D. Ram, R. Hashmi, S. Chakraverty, R. Moritz Middeke, J. Giebel, S. Sarkar, R. Gowda, M. Gunes, S. Stefanelli, T. Lee, S. J. Teshima, T. Locatelli, F. |
| author_facet | Zeiser, R. Russo, D. Ram, R. Hashmi, S. Chakraverty, R. Moritz Middeke, J. Giebel, S. Sarkar, R. Gowda, M. Gunes, S. Stefanelli, T. Lee, S. J. Teshima, T. Locatelli, F. |
| author_sort | Zeiser, R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429566 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94295662022-08-31 P1389: RUXOLITINIB DEMONSTRATES A GREATER CORTICOSTEROID-SPARING EFFECT THAN BEST AVAILABLE THERAPY IN PATIENTS WITH CORTICOSTEROID-REFRACTORY/DEPENDENT CHRONIC GRAFT-VS-HOST DISEASE Zeiser, R. Russo, D. Ram, R. Hashmi, S. Chakraverty, R. Moritz Middeke, J. Giebel, S. Sarkar, R. Gowda, M. Gunes, S. Stefanelli, T. Lee, S. J. Teshima, T. Locatelli, F. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429566/ http://dx.doi.org/10.1097/01.HS9.0000848416.66197.62 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Zeiser, R. Russo, D. Ram, R. Hashmi, S. Chakraverty, R. Moritz Middeke, J. Giebel, S. Sarkar, R. Gowda, M. Gunes, S. Stefanelli, T. Lee, S. J. Teshima, T. Locatelli, F. P1389: RUXOLITINIB DEMONSTRATES A GREATER CORTICOSTEROID-SPARING EFFECT THAN BEST AVAILABLE THERAPY IN PATIENTS WITH CORTICOSTEROID-REFRACTORY/DEPENDENT CHRONIC GRAFT-VS-HOST DISEASE |
| title | P1389: RUXOLITINIB DEMONSTRATES A GREATER CORTICOSTEROID-SPARING EFFECT THAN BEST AVAILABLE THERAPY IN PATIENTS WITH CORTICOSTEROID-REFRACTORY/DEPENDENT CHRONIC GRAFT-VS-HOST DISEASE |
| title_full | P1389: RUXOLITINIB DEMONSTRATES A GREATER CORTICOSTEROID-SPARING EFFECT THAN BEST AVAILABLE THERAPY IN PATIENTS WITH CORTICOSTEROID-REFRACTORY/DEPENDENT CHRONIC GRAFT-VS-HOST DISEASE |
| title_fullStr | P1389: RUXOLITINIB DEMONSTRATES A GREATER CORTICOSTEROID-SPARING EFFECT THAN BEST AVAILABLE THERAPY IN PATIENTS WITH CORTICOSTEROID-REFRACTORY/DEPENDENT CHRONIC GRAFT-VS-HOST DISEASE |
| title_full_unstemmed | P1389: RUXOLITINIB DEMONSTRATES A GREATER CORTICOSTEROID-SPARING EFFECT THAN BEST AVAILABLE THERAPY IN PATIENTS WITH CORTICOSTEROID-REFRACTORY/DEPENDENT CHRONIC GRAFT-VS-HOST DISEASE |
| title_short | P1389: RUXOLITINIB DEMONSTRATES A GREATER CORTICOSTEROID-SPARING EFFECT THAN BEST AVAILABLE THERAPY IN PATIENTS WITH CORTICOSTEROID-REFRACTORY/DEPENDENT CHRONIC GRAFT-VS-HOST DISEASE |
| title_sort | p1389: ruxolitinib demonstrates a greater corticosteroid-sparing effect than best available therapy in patients with corticosteroid-refractory/dependent chronic graft-vs-host disease |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429566/ http://dx.doi.org/10.1097/01.HS9.0000848416.66197.62 |
| work_keys_str_mv | AT zeiserr p1389ruxolitinibdemonstratesagreatercorticosteroidsparingeffectthanbestavailabletherapyinpatientswithcorticosteroidrefractorydependentchronicgraftvshostdisease AT russod p1389ruxolitinibdemonstratesagreatercorticosteroidsparingeffectthanbestavailabletherapyinpatientswithcorticosteroidrefractorydependentchronicgraftvshostdisease AT ramr p1389ruxolitinibdemonstratesagreatercorticosteroidsparingeffectthanbestavailabletherapyinpatientswithcorticosteroidrefractorydependentchronicgraftvshostdisease AT hashmis p1389ruxolitinibdemonstratesagreatercorticosteroidsparingeffectthanbestavailabletherapyinpatientswithcorticosteroidrefractorydependentchronicgraftvshostdisease AT chakravertyr p1389ruxolitinibdemonstratesagreatercorticosteroidsparingeffectthanbestavailabletherapyinpatientswithcorticosteroidrefractorydependentchronicgraftvshostdisease AT moritzmiddekej p1389ruxolitinibdemonstratesagreatercorticosteroidsparingeffectthanbestavailabletherapyinpatientswithcorticosteroidrefractorydependentchronicgraftvshostdisease AT giebels p1389ruxolitinibdemonstratesagreatercorticosteroidsparingeffectthanbestavailabletherapyinpatientswithcorticosteroidrefractorydependentchronicgraftvshostdisease AT sarkarr p1389ruxolitinibdemonstratesagreatercorticosteroidsparingeffectthanbestavailabletherapyinpatientswithcorticosteroidrefractorydependentchronicgraftvshostdisease AT gowdam p1389ruxolitinibdemonstratesagreatercorticosteroidsparingeffectthanbestavailabletherapyinpatientswithcorticosteroidrefractorydependentchronicgraftvshostdisease AT guness p1389ruxolitinibdemonstratesagreatercorticosteroidsparingeffectthanbestavailabletherapyinpatientswithcorticosteroidrefractorydependentchronicgraftvshostdisease AT stefanellit p1389ruxolitinibdemonstratesagreatercorticosteroidsparingeffectthanbestavailabletherapyinpatientswithcorticosteroidrefractorydependentchronicgraftvshostdisease AT leesj p1389ruxolitinibdemonstratesagreatercorticosteroidsparingeffectthanbestavailabletherapyinpatientswithcorticosteroidrefractorydependentchronicgraftvshostdisease AT teshimat p1389ruxolitinibdemonstratesagreatercorticosteroidsparingeffectthanbestavailabletherapyinpatientswithcorticosteroidrefractorydependentchronicgraftvshostdisease AT locatellif p1389ruxolitinibdemonstratesagreatercorticosteroidsparingeffectthanbestavailabletherapyinpatientswithcorticosteroidrefractorydependentchronicgraftvshostdisease |